Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Cancer Genetics and Cytogenetics
|
November 1, 1985
Mapping of amplified c-myb oncogene, sister chromatid exchanges, and karyotypic analysis of the COLO 205 colon carcinoma cell line
R Winqvist, S Knuutila, D Leprince, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
September 1, 1995
The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins
O Albagli, P Dhordain, C Deweindt, et al.
Virology
|
June 1, 1993
A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1
D Leprince, P Crepieux, V Laudet, et al.
Biochemical and Biophysical Research Communications
|
January 15, 1993
Evolution of the ets gene family
V Laudet, C Niel, M Duterque-Coquillaud, et al.
Oncogene
|
April 4, 1996
Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness
C Garrido, D Leprince, S Plaza, et al.
Nucleic Acids Research
|
September 25, 1994
A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins
N Soudant, O Albagli, P Dhordain, et al.
Oncogene
|
July 1, 1992
Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features
O Albagli, A Flourens, P Crepieux, et al.
Gene Expression
|
January 1, 1993
The two functionally distinct amino termini of chicken c-ets-1 products arise from alternative promoter usage
P Crepieux, D Leprince, A Flourens, et al.
Oncogene
|
November 19, 2008
Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control
B Zhang, K J Chambers, D Leprince, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein
J Ghysdael, A Gegonne, P Pognonec, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Cancer Genetics and Cytogenetics
|
November 1, 1985
Mapping of amplified c-myb oncogene, sister chromatid exchanges, and karyotypic analysis of the COLO 205 colon carcinoma cell line
R Winqvist, S Knuutila, D Leprince, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
September 1, 1995
The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins
O Albagli, P Dhordain, C Deweindt, et al.
Virology
|
June 1, 1993
A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1
D Leprince, P Crepieux, V Laudet, et al.
Biochemical and Biophysical Research Communications
|
January 15, 1993
Evolution of the ets gene family
V Laudet, C Niel, M Duterque-Coquillaud, et al.
Oncogene
|
April 4, 1996
Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness
C Garrido, D Leprince, S Plaza, et al.
Nucleic Acids Research
|
September 25, 1994
A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins
N Soudant, O Albagli, P Dhordain, et al.
Oncogene
|
July 1, 1992
Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features
O Albagli, A Flourens, P Crepieux, et al.
Gene Expression
|
January 1, 1993
The two functionally distinct amino termini of chicken c-ets-1 products arise from alternative promoter usage
P Crepieux, D Leprince, A Flourens, et al.
Oncogene
|
November 19, 2008
Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control
B Zhang, K J Chambers, D Leprince, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein
J Ghysdael, A Gegonne, P Pognonec, et al.
Page
of 5